Reckitt Benckiser adds Durex and Scholl to its portfolio

The offer means that investors in SSL will receive 1,686c for every share, along with the proposed 11.6c per share of SSL’s final dividend of the year ending 31 March 2010.

The offer price and dividend represents roughly a 32.8 per cent premium to the SSL share price as of 20 July, according to Reckitt Benckiser.

Bart Becht, chief executive of the company, said that acquisition of SSL would provide a step change to Reckitt’s global health and personal care business.


GLOBAL – FMCG giant Reckitt Benckiser is to buy Durex condoms maker SSL for US$3.6 billion.

Reckitt Benckiser adds Durex and Scholl to its portfolio

The offer means that investors in SSL will receive 1,686c for every share, along with the proposed 11.6c per share of SSL’s final dividend of the year ending 31 March 2010.

The offer price and dividend represents roughly a 32.8 per cent premium to the SSL share price as of 20 July, according to Reckitt Benckiser.

Bart Becht, chief executive of the company, said that acquisition of SSL would provide a step change to Reckitt’s global health and personal care business. Leer más “Reckitt Benckiser adds Durex and Scholl to its portfolio”